Key result
Advanced CKD complicates ruling out HF alongside issues like dialysis fistula cardiotoxicity and pulmonary hypertension.
Why the study?
Patients with advanced CKD have frequently been excluded from large randomized trials, leaving everyday diagnostic challenges in heart failure not clearly addressed in guidelines.
This review highlights the diagnostic challenges of heart failure in patients with advanced chronic kidney disease, an area often excluded from large clinical trials.
Complicates HF diagnosis in advanced CKD; leaves open need for dedicated trials in this excluded population.
Is advanced chronic kidney disease (CKD) a cardiac “no man’s land”? Chronic heart failure (HF) is widely believed to be one of the most serious medical challenges of the 21st century. Moreover, the number of patients with CKD is increasing. To date, patients with estimated glomerular filtration rates <30 mL/min/1.73 m2 have frequently been excluded from large, randomized clinical trials. Although this situation is slowly changing, in everyday practice we continue to struggle with problems that are not clearly addressed in the guidelines. This literature review was conducted by an interdisciplinary group, which comprised a nephrologist, internal medicine specialists, and cardiologist. In this review, we discuss the difficulties in ruling out HF for patients with advanced CKD and issues regarding the cardiotoxicity of dialysis fistulas and the occurrence of pulmonary hypertension in patients with CKD. Due to the recent publication of the new HF guidelines by the European Society of Cardiology, this is a good time to address these difficult issues. Contrary to appearances, these are not niche issues, but problems that affect many patients.
No takes yet. Share an insight, caveat, or question.
Adamska-Wełnicka et al. (2021) conducted a review in Chronic Kidney Disease and Heart Failure. Advanced chronic kidney disease presents significant diagnostic challenges for ruling out heart failure, alongside issues like dialysis fistula cardiotoxicity and pulmonary hypertension.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: